{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:29:31Z","timestamp":1761488971017},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T00:00:00Z","timestamp":1344816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T00:00:00Z","timestamp":1344816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1038\/bmt.2012.141","type":"journal-article","created":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T14:17:46Z","timestamp":1344867466000},"page":"749-754","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Live (vaccines) from New York"],"prefix":"10.1038","volume":"48","author":[{"given":"C J","family":"Forlenza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T N","family":"Small","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,13]]},"reference":[{"key":"BFbmt2012141_CR1","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/9781444303537.ch108","volume-title":"Hematopoietic Cell Transplantation","author":"TN Small","year":"2009","unstructured":"Small TN . Vaccination of hematopoietic cell transplant recipients. In: Appelbaum F, Forman S, Blume KG, Thomas ED, (eds). Hematopoietic Cell Transplantation 108, 4th edn. Blackwell Science: Malden, MA 2009, pp 1664\u20131670."},{"key":"BFbmt2012141_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1586\/eci.10.103","volume":"7","author":"TN Small","year":"2011","unstructured":"Small TN, Cowan MJ . Immunization of hematopoietic stem cell transplant recipients against vaccine-preventable diseases. Expert Rev Clin Immunol 2011; 7: 193\u2013203.","journal-title":"Expert Rev Clin Immunol"},{"key":"BFbmt2012141_CR3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/bmt.2009.263","volume":"44","author":"P Ljungman","year":"2009","unstructured":"Ljungman P, Cordonnier C, Einsele H, Englund J, Machado CM, Storek J et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 2009; 44: 521\u2013526.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012141_CR4","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/infdis\/159.4.610","volume":"159","author":"P Ljungman","year":"1989","unstructured":"Ljungman P, Fridell E, L\u00f6nnqvist B, Bolme P, B\u00f6ttiger M, Gahrton G et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 1989; 159: 610\u2013615.","journal-title":"J Infect Dis"},{"key":"BFbmt2012141_CR5","first-page":"807","volume":"16","author":"K Pauksen","year":"1995","unstructured":"Pauksen K, Linde A, Ljungman P, Bolme P, L\u00f6nnerholm G, Oberg G et al. Specific T and B cell immunity to measles after allogeneic and autologous bone marrow transplantation. Bone Marrow Transplant 1995; 16: 807\u2013813.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012141_CR6","first-page":"633","volume":"17","author":"SM King","year":"1996","unstructured":"King SM, Saunders EF, Petric M, Gold R . Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients. Bone Marrow Transplant 1996; 17: 633\u2013636.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012141_CR7","first-page":"427","volume":"9","author":"K Pauksen","year":"1992","unstructured":"Pauksen K, Duraj V, Ljungman P, Sj\u00f6lin J, Oberg G, L\u00f6nnerholm G et al. Immunity to and immunization against measles, rubella, and mumps in patients after autologous bone marrow transplantation. Bone Marrow Transplant 1992; 9: 427\u2013432.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012141_CR8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.V84.2.657.657","volume":"84","author":"P Ljungman","year":"1994","unstructured":"Ljungman P, Lewensohn-Fuchs I, Hammarstr\u00f6m V, Aschan J . Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation. Blood 1994; 84: 657\u2013663.","journal-title":"Blood"},{"key":"BFbmt2012141_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/sj.bmt.1704634","volume":"34","author":"P Ljungman","year":"2004","unstructured":"Ljungman P, Aschan J, Barkholt L, Broliden PA, Gustafsson B, Lewensohn-Fuchs I et al. Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease. Bone Marrow Transplant 2004; 34: 589\u2013593.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012141_CR10","first-page":"455","volume":"15","author":"P Ljungman","year":"1995","unstructured":"Ljungman P, Cordonnier C, De Bock R, Einsele H, Engelhard D, Grundy J et al. Immunisations after bone marrow transplantation: results of a European survey and recommendations from infectious disease working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1995; 15: 455\u2013460.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012141_CR11","first-page":"1","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","unstructured":"Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR 2000; 49: 1\u2013128.","journal-title":"MMWR"},{"key":"BFbmt2012141_CR12","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/sj.bmt.1704870","volume":"35","author":"P Ljungman","year":"2005","unstructured":"Ljungman P, Engelhard D, de la C\u00e1mara R, Einsele H, Locasciulli A, Martino R et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 2005; 35: 737\u2013746.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012141_CR13","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1182\/blood-2002-01-0212","volume":"99","author":"P Shaw","year":"2002","unstructured":"Shaw P, Bleakley M, Burgess M . Safety of early immunization against measles\/mumps\/rubella after bone marrow transplantation. Blood 2002; 99: 3486.","journal-title":"Blood"},{"key":"BFbmt2012141_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/sj.bmt.1704878","volume":"35","author":"C Machado","year":"2005","unstructured":"Machado C, de Souza V, Sumita LM, da Rocha IF, Dulley FL, Pannuti CS . Early measles vaccination in bone marrow transplant recipients. Bone Marrow Transplant 2005; 35: 787\u2013791.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012141_CR15","first-page":"125","volume":"59","author":"Center for Disease Control and Prevention","year":"2010","unstructured":"Center for Disease Control and Prevention. Update: mumps outbreak\u2014New York and New Jersey, June 2009\u2013January 2010. MMWR Morb Mortal Wkly Rep 2010; 59: 125\u2013129.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"BFbmt2012141_CR16","first-page":"253","volume":"61","author":"Center for Disease Control and Prevention","year":"2011","unstructured":"Center for Disease Control and Prevention. Measles\u2014United States, 2011. MMWR Morb Mortal Wkly Rep 2011; 61: 253\u2013257.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"BFbmt2012141_CR17","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1056\/NEJMp1202396","volume":"366","author":"EK Mulholland","year":"2012","unstructured":"Mulholland EK, Griffiths UK, Biellik R . Measles in the 21st century. N Engl J Med 2012; 366: 1755\u20131757.","journal-title":"N Engl J Med"},{"key":"BFbmt2012141_CR18","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD et al. Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271\u20132284.","journal-title":"N Engl J Med"},{"key":"BFbmt2012141_CR19","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/clind\/16.5.654","volume":"16","author":"MM Mustafa","year":"1993","unstructured":"Mustafa MM, Weitman SD, Winick NJ, Bellini WJ, Timmons CF, Siegel JD . Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavarin and review of literature. Clin Infect Dis 1993; 16: 654\u2013660.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2012141_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1442-200X.1996.tb03472.x","volume":"38","author":"T Nakano","year":"1996","unstructured":"Nakano T, Shimono Y, Sugigayma K, Nishihara H, Higashigawa M, Komada Y et al. Clinical features of measles in immunocompromised children. Acta Paediatr Jpn 1996; 38: 212\u2013217.","journal-title":"Acta Paediatr Jpn"},{"key":"BFbmt2012141_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1182\/blood.V99.1.83","volume":"99","author":"C Machado","year":"2002","unstructured":"Machado C, Goncalves F, Pannuti C, Dulley FL, de Souza VA . Measles in bone marrow transplant recipients during an outbreak in S\u00e3o Paulo, Brazil. Blood 2002; 99: 83\u201387.","journal-title":"Blood"},{"key":"BFbmt2012141_CR22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1086\/511641","volume":"44","author":"SR Patel","year":"2007","unstructured":"Patel SR, Ortin M, Cohen BJ, Borrow R, Irving D, Sheldon J et al. Revaccination with measles, tetanus, poliovirus, haemophilus influenzae type b, meningococcus c, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. CID 2007; 44: 625\u2013634.","journal-title":"CID"},{"key":"BFbmt2012141_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1365-2141.2011.08913.x","volume":"156","author":"H Inaba","year":"2011","unstructured":"Inaba H, Hartford CM, Pei D, Posner MJ, Yang J, Hayden RT et al. Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2011; 156: 109\u2013117.","journal-title":"Br J Haematol"},{"key":"BFbmt2012141_CR24","first-page":"2226","volume":"104","author":"TN Small","year":"2004","unstructured":"Small TN, Papadopoulos EB, Boulad F, Kernan NA, Ford R, Taylor J et al. Vaccine responses following unmodified or T cell depleted unrelated and mismatched Related HCT. ASH Annual Meeting 2004; 104: 2226.","journal-title":"ASH Annual Meeting"},{"key":"BFbmt2012141_CR25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1399-3062.2007.00247.x","volume":"10","author":"DH Kim","year":"2008","unstructured":"Kim DH, Messner H, Minden M, Gupta V, Kuruvilla J, Wright J et al. Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders. Transpl Infect Dis 2008; 10: 90\u201398.","journal-title":"Transpl Infect Dis"},{"key":"BFbmt2012141_CR26","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.bbmt.2009.03.003","volume":"15","author":"M Onozawa","year":"2009","unstructured":"Onozawa M, Hashino S, Haseyama Y, Hirayama Y, Iizuka S, Ishida T et al. Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group. Biol Blood Marrrow Transplant 2009; 15: 724\u2013729.","journal-title":"Biol Blood Marrrow Transplant"},{"key":"BFbmt2012141_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jinf.2008.03.004","volume":"57","author":"AJ Tunbridge","year":"2008","unstructured":"Tunbridge AJ, Breuer J, Jeffery KJ . British Infection Society. Chickenpox in adults. J Infect 2008; 57: 95\u2013102.","journal-title":"J Infect"},{"key":"BFbmt2012141_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S1083-8791(00)70051-6","volume":"6","author":"Y Koc","year":"2000","unstructured":"Koc Y, Miller KB, Schenkein DP, Griffith J, Akhtar M, DesJardin J et al. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant 2000; 6: 44\u201349.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012141_CR29","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/sj.bmt.1704959","volume":"35","author":"KJ Thomson","year":"2005","unstructured":"Thomson KJ, Hart DP, Banerjee L, Ward KN, Peggs KS, Mackinnon S . The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation. Bone Marrow Transplant 2005; 35: 1065\u20131069.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012141_CR30","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1182\/blood-2007-03-077644","volume":"110","author":"V Erard","year":"2007","unstructured":"Erard V, Guthrie KA, Varley C, Heugel J, Wald A, Flowers ME et al. One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation. Blood 2007; 110: 3071\u20133077.","journal-title":"Blood"},{"key":"BFbmt2012141_CR31","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/sj.bmt.1700909","volume":"20","author":"A Sauerbrei","year":"1997","unstructured":"Sauerbrei A, Prager J, Hengst U, Zintl F, Wutzler P . Varicella vaccination in children after bone marrow transplantation. Bone Marrow Transplant 1997; 20: 381\u2013383.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012141_CR32","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00520-003-0527-8","volume":"11","author":"P Ljungman","year":"2003","unstructured":"Ljungman P, Wang FZ, Nilsson C, Solheim V, Linde A . Vaccination of autologous stem cell transplant recipients with live varicella vaccine: a pilot study. Support Care Cancer 2003; 11: 739\u2013741.","journal-title":"Support Care Cancer"},{"key":"BFbmt2012141_CR33","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/bmt.2010.31","volume":"45","author":"SC Kussmaul","year":"2010","unstructured":"Kussmaul SC, Horn BN, Dvorak CC, Abramovitz L, Cowan MJ, Weintrub PS . Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs. Bone Marrow Transplant 2010; 45: 1602\u20131606.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012141_CR34","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.bbmt.2011.05.006","volume":"17","author":"JF Chou","year":"2011","unstructured":"Chou JF, Kernan NA, Prockop S, Heller G, Scaradavou A, Kobos R et al. Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT). Biol Blood Marrow Transplant 2011; 17: 1708\u20131713.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012141_CR35","first-page":"1","volume":"56","author":"M Marin","year":"2007","unstructured":"Marin M, G\u00fcris D, Chaves SS, Schmid S, Seward JF, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56: 1\u201340.","journal-title":"MMWR Recomm Rep"},{"key":"BFbmt2012141_CR36","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s11606-008-0558-4","volume":"23","author":"KK Curtis","year":"2008","unstructured":"Curtis KK, Connolly MK, Northfelt DW . Live attenuated varicella zoster vaccination of an immunocompromised patient. J Gen Intern Med 2008; 23: 648\u2013649.","journal-title":"J Gen Intern Med"},{"key":"BFbmt2012141_CR37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1056\/NEJMoa013441","volume":"347","author":"A Hata","year":"2002","unstructured":"Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, Blume K et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. New Eng J Med 2002; 347: 26\u201334.","journal-title":"New Eng J Med"},{"key":"BFbmt2012141_CR38","first-page":"1124","volume":"20","author":"J King","year":"2001","unstructured":"King J, Fast PE, Zangwill KM, Weinberg GA, Wolff M, Yan L et al. Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children. Pediatr. Infect. Dis J 2001; 20: 1124\u20131131.","journal-title":"Dis J"},{"key":"BFbmt2012141_CR39","first-page":"1475","volume":"204","author":"S Carr","year":"2011","unstructured":"Carr S, Allison K, Van De Velde LA, Zhang K, English EY, Iverson A et al. Safety and Immunogenicity of live attenuated and inactivated Influenza Vaccines in children with cancer. J Infect. Dis 2011; 204: 1475\u20131482.","journal-title":"Dis"},{"key":"BFbmt2012141_CR40","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1016\/j.vaccine.2011.03.097","volume":"29","author":"N Halasa","year":"2011","unstructured":"Halasa N, Englund JA, Nachman S, Weinberg GA, Huber VC, Allison K et al. Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer. Vaccine 2011; 29: 4110\u20134115.","journal-title":"Vaccine"},{"key":"BFbmt2012141_CR41","first-page":"1","volume":"58","author":"Center for Disease Control and Prevention","year":"2009","unstructured":"Center for Disease Control and Prevention. Prevention of rotavirus gastroenteritis among Infants and children: Recommendations of the Advisory Committee on Immunization practices\u2014United States. MMWR Morb Mortal Wkly Rep 2009; 58: 1\u201325.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"BFbmt2012141_CR42","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/sj.bmt.1705127","volume":"36","author":"E Liakopoulou","year":"2005","unstructured":"Liakopoulou E, Mutton K, Carrington D, Robinson S, Steward CG, Goulden NJ et al. Rotavirus as a significant cause of prolonged diarrhoeal illness and morbidity following allogeneic bone marrow transplantation. Bone Marrow Transplant 2005; 36: 691\u2013694.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012141_CR43","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/NEJMoa0904485","volume":"362","author":"NC Patel","year":"2010","unstructured":"Patel NC, Hertel PM, Estes MK, de la Morena M, Petru AM, Noroski LM et al. Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N Engl J Med 2010; 362: 314\u2013319.","journal-title":"N Engl J Med"},{"key":"BFbmt2012141_CR44","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1016\/j.vaccine.2004.01.026","volume":"22","author":"S Kitchener","year":"2004","unstructured":"Kitchener S . Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX. Vaccine 2004; 22: 2103\u20132105.","journal-title":"Vaccine"},{"key":"BFbmt2012141_CR45","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1600-0609.2004.00218.x","volume":"72","author":"R Gowda","year":"2004","unstructured":"Gowda R, Cartwright K, Bremner JAG . Yellow fever vaccine: a successful vaccination of an immunocompromised patient. Eur J Haematol 2004; 72: 299\u2013301.","journal-title":"Eur J Haematol"},{"key":"BFbmt2012141_CR46","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1708-8305.2009.00336.x","volume":"16","author":"JA Yax","year":"2009","unstructured":"Yax JA, Farnon EC, Cary Engleberg N . Successful immunization of an allogeneic bone marrow transplant recipient with live, attenuated yellow Fever vaccine. J Travel Med 2009; 16: 365\u2013367.","journal-title":"J Travel Med"},{"key":"BFbmt2012141_CR47","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood.V93.2.467","volume":"93","author":"TN Small","year":"1999","unstructured":"Small TN, Papadopoulos EB, Boulad F, Black P, Castro-Malaspina H, Childs BH et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 1999; 93: 467\u2013480.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2012141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012141","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T18:37:13Z","timestamp":1659119833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2012141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,13]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["BFbmt2012141"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2012.141","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,13]]},"assertion":[{"value":"26 June 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}